Gum Surgery (Periodontal Surgery) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Periodontal surgery — commonly referred to as gum surgery — encompasses a range of surgical procedures performed by periodontists or oral surgeons to treat advanced gum disease (periodontitis), to regenerate lost bone and gum tissue, to correct gum recession, and to improve the architecture of the gingiva and alveolar bone around teeth.

Periodontitis is classified using the 2017 AAP/EFP World Workshop staging and grading system. Stage I–II disease can usually be managed with non-surgical treatment alone (scaling and root planing, SRP). However, Stage III–IV disease — characterised by probing depths ≥6 mm, furcation involvement Class II–III, angular bone loss, and tooth mobility — frequently requires surgical access to achieve adequate debridement and tissue recontouring.

According to the British Society of Periodontology and the American Academy of Periodontology (AAP), surgical intervention is indicated when residual pocket depths of ≥5 mm with bleeding on probing persist at the reassessment visit 8–12 weeks after Phase 1 non-surgical treatment.

Surgery is not undertaken until the patient has demonstrated adequate plaque control (full-mouth plaque score below 20%) and has completed cause-related therapy. This ensures the surgical site heals in a low-bacterial environment and improves long-term outcomes. This guide covers all major categories of periodontal surgery, their indications, evidence base, and expected outcomes.

Gum surgery addresses a spectrum of conditions affecting the periodontium — the supporting structures of the teeth including the gingiva, periodontal ligament, cementum, and alveolar bone.

Chronic and Aggressive Periodontitis (Stage III–IV)

Advanced periodontitis with pocket depths ≥6 mm, furcation involvement (Class II or III), or angular (vertical) bone loss on radiographs often cannot be adequately debrided by SRP alone due to restricted instrument access. Open flap surgery allows direct visualisation of the root surface and bone defects.

Gingival Overgrowth (Gingival Hyperplasia)

Drug-induced gingival enlargement (caused by ciclosporin, nifedipine, or phenytoin), hereditary gingival fibromatosis, or inflammatory gingival enlargement that creates pseudo-pockets unresponsive to non-surgical treatment.

Gingival Recession and Root Exposure

Recession Miller Class I–III (Cairo RT1–RT2) causing root sensitivity, aesthetics concerns, or progressive attachment loss. Root coverage surgery (gingival grafting) is the primary treatment.

Insufficient Attached Gingiva

Less than 2 mm of attached keratinised gingiva — particularly around implants or planned restorations — is associated with increased recession risk and requires augmentation.

Short Clinical Crown / Altered Passive Eruption

When teeth are short due to altered passive eruption or when subgingival decay or fractures require surgical crown lengthening to establish an adequate biologic width before restoration.

Infrabony Defects and Furcation Lesions

Angular bone defects adjacent to teeth and bone loss affecting the bifurcation or trifurcation of multi-rooted teeth, which can sometimes be regenerated using guided bone regeneration techniques.

Patient selection for periodontal surgery follows a structured decision-making process. Surgery is indicated only when non-surgical treatment has been completed and adequately reassessed, and when the patient is able to maintain the surgical outcome.

Clinical Criteria

• Probing depths ≥5 mm with bleeding on probing (BOP) persisting at 8–12 week reassessment after SRP.
• Furcation involvement Class II or III in multi-rooted teeth — sites that cannot be adequately cleaned by root planing or by the patient at home.
• Angular bone defects ≥3 mm deep on periapical radiographs (CBCT), suitable for regenerative procedures.
• Gingival recession ≥2 mm with patient-reported sensitivity or aesthetic concern, and adequate keratinised tissue on the adjacent donor site.
• Insufficient clinical crown height (≤4 mm) preventing placement of a well-fitting restoration within the biologic width.

Patient Factors Favouring Surgery

• Excellent home oral hygiene (full-mouth plaque score below 20%).
• Non-smoker, or smoking cessation achieved — smoking significantly impairs healing and regenerative outcomes.
• Controlled systemic conditions (HbA1c ≤7.0% in diabetics; no immunosuppression that cannot be modified).
• Sufficient bone volume to support regenerative procedures.

Contraindications

• Uncontrolled systemic disease (uncontrolled diabetes, blood dyscrasias, anticoagulation that cannot be bridged).
• Active head and neck radiotherapy within the previous 12 months.
• Terminal teeth with a hopeless prognosis — extraction is preferred over surgery.
• Patient unable to maintain adequate plaque control — surgery in the absence of plaque control leads to rapid recurrence.

Periodontal surgery encompasses several distinct procedures, often combined in the same surgical session depending on the distribution of disease and treatment goals.

1. Gingivectomy

Excision of excess gingival tissue to eliminate suprabony pockets and restore a normal gingival contour. Indicated for gingival overgrowth and pseudo-pockets where the bone level is not affected. Can be performed with conventional scalpel, electrosurgery, or diode laser. Results are predictable for soft-tissue-only cases; it is not appropriate where bone loss has occurred.

2. Open Flap Debridement (OFD) — Modified Widman Flap (Ramfjord-Nissle Procedure)

The Modified Widman Flap, described by Ramfjord and Nissle in 1974, is the most widely used resective and access surgical technique in periodontology. A mucoperiosteal flap is elevated to expose root surfaces and alveolar bone, enabling thorough root surface instrumentation under direct vision. After debridement, the flap is repositioned at or slightly coronal to the alveolar crest and sutured. OFD consistently achieves greater pocket depth reduction than SRP alone in sites ≥6 mm (average gain of 1.5–2.5 mm of attachment level).

3. Osseous Surgery (Resective Bone Surgery)

In cases of irregular or 'positive' bone architecture (bony ledges, exostoses, shallow supra-crestal defects), the bone is carefully recontoured using rotary instruments or hand chisels to create a physiological morphology that the patient can self-cleanse. Most effective for Stage III–IV periodontitis with horizontal bone loss. Evidence supports long-term tooth retention when combined with supportive periodontal therapy.

4. Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR)

Regenerative surgery aims to reconstruct lost periodontal structures — bone, periodontal ligament, and cementum. The defect is filled with a bone graft material (autograft, allograft, xenograft such as Bio-Oss, or alloplast) and covered with a resorbable or non-resorbable barrier membrane (collagen, e-PTFE) to exclude fast-growing epithelium from the defect and allow slower-growing bone and PDL cells to repopulate it. Meta-analyses show average clinical attachment level (CAL) gains of 2–4 mm and radiographic bone fill of 50–70% in suitable 2-wall or 3-wall intrabony defects.

5. Gingival Grafting Procedures

Three principal techniques are used to augment keratinised gingiva or achieve root coverage:

• Connective Tissue Graft (CTG): A subepithelial connective tissue graft harvested from the hard palate is tunnelled or placed under a partial-thickness recipient flap. This is the gold standard for root coverage, achieving complete coverage in 80–95% of Miller Class I/II (Cairo RT1) recessions.
• Free Gingival Graft (FGG): A full-thickness mucosal strip from the palate is placed on a periosteal bed at the recipient site. Primarily used to augment the zone of attached keratinised gingiva rather than for root coverage (resulting aesthetics are less favourable due to colour mismatch).
• Pedicle Graft (Laterally Positioned Flap / Coronally Advanced Flap): Adjacent gingival tissue is rotated or advanced over the recession defect, preserving its own blood supply. The coronally advanced flap (CAF) combined with CTG gives the highest root coverage success rates in the literature.

6. Crown Lengthening Surgery

Surgical exposure of additional tooth structure by apically repositioning the gingiva, with or without alveolar bone reduction, to establish an adequate biologic width (≥3 mm of combined sulcus depth + junctional epithelium + connective tissue attachment) before restoration. Required when decay, fracture, or the planned restoration margin is subgingival.

When performed in appropriately selected patients and followed by structured maintenance, periodontal surgery offers significant and durable clinical benefits.

• Superior pocket depth reduction: Systematic reviews confirm that surgical treatment achieves statistically and clinically significantly greater pocket depth reduction and clinical attachment level gain than SRP alone in moderate-to-deep pockets (≥5 mm), with differences becoming more pronounced over 5–10 years of follow-up.
• Direct visualisation and more complete calculus removal: Open access allows the periodontist to detect and remove calculus deposits that cannot be reached subgingivally with hand instruments, particularly on root concavities, furcation entrances, and the lingual surfaces of lower molars.
• Bone regeneration: GBR with bone graft and membrane can reverse bone loss in suitable intrabony defects, restoring the tooth's bony support and potentially converting an otherwise hopeless tooth to a treatable one.
• Gingival recession repair: Connective tissue grafting achieves complete root coverage in the majority of suitable cases, eliminating cold sensitivity and improving aesthetics — outcomes that are maintained at 10-year follow-up in non-smokers.
• Reduced systemic inflammatory burden: Successful treatment of periodontitis is associated with reductions in systemic inflammatory markers (CRP, IL-6) and — in randomised trials — improvements in glycaemic control in patients with type 2 diabetes.
• Long-term tooth retention: With regular supportive periodontal therapy (SPT), surgically treated teeth have an excellent long-term prognosis. Studies from the landmark maintenance studies (Lindhe, Nyman, Axelsson) show tooth loss rates of 1–2% over 15 years in maintained patients.

Periodontal surgery is a well-established and safe procedure when performed by trained periodontists. However, patients should be informed of the following potential risks:

Post-Operative Pain and Swelling

Mild to moderate discomfort, swelling, and bruising are expected after all periodontal surgical procedures. Pain is typically managed with NSAIDs (ibuprofen 400–600 mg three times daily) and, if required, weak opioid analgesia for the first 48–72 hours. Swelling peaks at 48–72 hours and resolves within 5–7 days.

Increased Tooth Sensitivity

Resective procedures that reduce pocket depth inevitably expose root surfaces to the oral environment, leading to cold sensitivity that can last several weeks. Desensitising toothpastes (fluoride, potassium nitrate) and in-office fluoride varnish applications accelerate resolution.

Gingival Recession After Resective Surgery

Pocket reduction surgery reduces pocket depth partly by apical migration of the gingival margin, which may be aesthetically unacceptable in the upper anterior region. This should be discussed in detail during treatment planning — regenerative approaches are preferred anteriorly.

Infection and Delayed Healing

Post-operative infection occurs in fewer than 3% of periodontal surgical cases. Patients are usually given a short course of chlorhexidine 0.12% mouth rinse for 2–4 weeks post-operatively. Systemic antibiotics are reserved for specific indications (aggressive periodontitis, immunocompromised patients).

Incomplete Regeneration

GBR does not always achieve the predicted bone fill. Outcomes depend on defect morphology (3-wall defects regenerate better than 1-wall), membrane stability, absence of smoking, and infection control. Membrane exposure is the most common complication of guided regeneration, occurring in 10–30% of cases and reducing bone fill by approximately 50%.

Relapse Without Maintenance

Periodontal surgery does not cure periodontitis — it creates an environment that the patient and clinician can maintain together. Without regular SPT (every 3 months initially), pocket depths and bone loss will recur. Smoking, uncontrolled diabetes, and stress are the principal risk factors for recurrence.

The post-surgical phase is as critical as the surgery itself. Structured follow-up and lifelong supportive periodontal therapy (SPT) are mandatory for long-term success.

Immediate Post-Operative Instructions (0–2 Weeks)

• Soft diet for 1 week; avoid spicy, hot, or hard foods around the surgical site.
• Chlorhexidine 0.12% rinse twice daily for 2–4 weeks — mechanical brushing is suspended at the surgical site during this period.
• Suture removal at 7–10 days (unless resorbable sutures were used).
• Avoid smoking for a minimum of 4 weeks to optimise healing.

First Post-Operative Review (6–8 Weeks)

• Recommence mechanical oral hygiene at the surgical sites with an ultra-soft brush and interdental cleaning.
• Clinical assessment of healing: residual pocket depths, attachment level measurement, BOP.
• Adjunctive measures (desensitising agents, dietary advice) as indicated.

3-Month Assessment

Full periodontal charting to compare with pre-surgical baseline. This is the critical decision point: sites that have responded well are enrolled in SPT; sites with residual disease may require further intervention.

Supportive Periodontal Therapy (SPT)

After active treatment is complete, the patient enters a maintenance programme. The standard recall interval is 3 months for the first year, extended to every 4–6 months for stable, well-maintained patients. Each SPT visit includes full-mouth charting, BOP assessment, professional supragingival and subgingival cleaning, and reinforcement of home care. Radiographic review is scheduled every 3–5 years or when clinical deterioration is detected.

Periodontal surgery costs vary significantly by procedure type, number of teeth or quadrants involved, and the country of treatment.

Key Cost Drivers

• Procedure type: A simple gingivectomy of 2–3 teeth costs far less than a full-quadrant regenerative procedure with bone graft, membrane, and biologics (e.g., enamel matrix derivative such as Emdogain).
• Number of quadrants: Full-mouth periodontal surgery is often staged over 2–4 appointments, each representing a separate procedural cost.
• Materials used: Bone graft materials (particularly allografts and xenografts) and barrier membranes add USD 200–800 per surgical site. Growth factors and biologics add further cost.
• Anaesthesia: Procedures are performed under local anaesthesia as standard. IV sedation for anxious patients adds USD 300–700.
• Country and practice setting: Private specialist periodontist fees in the UK or US are substantially higher than general practitioner periodontal treatment in India, Hungary, or Turkey — countries well established as dental tourism destinations.

Approximate Cost Ranges by Procedure (Per Quadrant / Per Site)

• Open flap debridement (per quadrant): USD 500–1,500 (US/UK); USD 100–350 (India/Eastern Europe)
• GBR with bone graft and membrane (per site): USD 1,500–3,500 (US/UK); USD 300–800 (India/Turkey)
• Connective tissue graft for root coverage (per tooth): USD 800–2,000 (US/UK); USD 200–500 (India)
• Crown lengthening (per tooth): USD 700–1,800 (US/UK); USD 150–400 (India)

Not all patients with periodontitis require surgery. Several non-surgical and adjunctive approaches can achieve significant disease control, and for some patients they may be adequate indefinitely.

Non-Surgical Scaling and Root Planing (SRP)

SRP — also called Phase 1 therapy or cause-related therapy — is always the first treatment for periodontitis regardless of stage. Systematic reviews show that SRP reduces pocket depth by 1.0–1.5 mm and gains 0.5–1.0 mm of clinical attachment on average in pockets of 4–6 mm. In Stage I–II disease, SRP combined with supragingival maintenance is often sufficient for long-term stability without surgery.

Adjunctive Antimicrobial Therapy

For specific clinical scenarios — aggressive periodontitis, Stage III–IV generalised disease, or recurrent disease in maintenance patients — adjunctive systemic antibiotics (amoxicillin + metronidazole, 500 mg each, three times daily for 7 days) combined with SRP provide significant additional clinical benefit over SRP alone, according to the 2020 EFP clinical practice guidelines. Local antimicrobial delivery (minocycline microspheres, chlorhexidine chips) offers modest additional benefit in specific persistent pockets.

Host Modulation Therapy

Sub-antimicrobial dose doxycycline (SDD, 20 mg twice daily for 3–9 months) inhibits matrix metalloproteinases (MMPs) responsible for collagen destruction in the periodontium and is licensed as an adjunct to SRP in several countries. It modulates the host inflammatory response without the antimicrobial effect, reducing the risk of antibiotic resistance.

Tooth Extraction

For teeth with a truly hopeless prognosis (furcation involvement Class III, bone loss to the apex, tooth mobility Grade 3), extraction followed by implant placement or bridgework may be more cost-effective and predictable than attempting regenerative surgery.

Dental Implants

Where teeth are lost or extracted due to advanced periodontitis, dental implants provide a functional and aesthetic replacement. However, patients with a history of periodontitis have a higher risk of peri-implantitis (inflammation around the implant analogous to periodontitis) and require particularly rigorous maintenance protocols.